GRAND RAPIDS — In the three years since Peter Jones moved from Los Angeles to Grand Rapids, he’s helped to more than double the amount of federal research funding that Van Andel Institute receives.
GRAND RAPIDS — The sale of RespondWell LLC last summer for an undisclosed sum was the first exit recorded by venture capital firm Michigan Accelerator Fund.
GRAND RAPIDS — After closing last spring on a $2 million venture capital investment, Ted Spooner began seeking another $8 million for his company, RespondWell LLC, a Grand Rapids-based telehealth provider.
The availability of scientific and executive management talent and the access to later-stage investment capital remain major issues for Michigan’s life sciences industry.
GRAND RAPIDS — The managers of Michigan Accelerator Fund I are seeking to raise up to $5 million from investors to provide further financial backing to portfolio companies.
A new roadmap aims to reboot efforts to build Michigan’s life sciences industry and compete with similar clusters around the U.S. and the world.
Venture capital investing in Michigan had one of its best years ever in 2012, setting the stage for what one venture investor sees as “another very big year” for further growth.
Investors say once Michigan’s maturing life sciences industry can regularly generate success stories, the chances are that more venture capital will follow.
In an industry notorious for long — and expensive — development cycles, Tetra Discovery Partners LLC has a decided edge: a burn rate of almost zero, according to its founder.
After closing fundraising on its flagship fund to invest more than $15.1 million in early stage Michigan-based businesses, a Grand Rapids venture fund can now focus on building its investment portfolio and recording its first exit.